LabCorp 2007 Annual Report Download - page 2

Download and view the complete annual report

Please find page 2 of the 2007 LabCorp annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 60

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60

LabCorp conducts
clinical trial testing through its Esoterix Clinical
Our clients include
managed
clinical labs,
o learn
visit our Web
2005
$ 3,327.6
1,390.3
618.1
$ 386.2
$ 2.89
$ 2.71
Financial Highlights
Laboratory Corporation of America® Holdings
(LabCorp), a S&P 500 company, is a
pioneer in commercializing new diagnostic
technologies and the fi rst in its industry to
embrace genomic testing. With annual
revenues of $4.1 billion in 2007, more than
26,000 employees nationwide, and more
than 220,000 clients, LabCorp offers clinical
assays, ranging from routine blood analyses to
HIV and genomic testing. LabCorp combines
its expertise in innovative clinical testing
technology with its Centers of Excellence:
The Center for Molecular Biology and
Pathology, National Genetics Institute, Inc.,
ViroMed Laboratories, Inc., The Center for
Esoteric Testing, DIANON Systems, Inc.,
US LABS, and Esoterix. LabCorp conducts
clinical trial testing through its Esoterix Clinical
Trials Services division. Our clients include
physicians, government agencies, managed
care organizations, hospitals, clinical labs,
and pharmaceutical companies. To learn
more about our organization, visit our Web
Site at: www.LabCorp.com.
Business Description
Years Ended December 31,
(in millions, except per share data) 2007 2006 2005
Net sales $ 4,068.2 $ 3,590.8 $ 3,327.6
Gross profit 1,691.2 1,529.4 1,390.3
Operating income 777.0 697.1 618.1
Net earnings $ 476.8 $ 431.6 $ 386.2
Basic earnings per common share $ 4.08 $ 3.48 $ 2.89
Diluted earnings per common share $ 3.93 $ 3.24 $ 2.71